Autopsy report · NCT00958022
Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer
Cause of deathFunding or business
“Based on the tolerabilty challenges of the combination”
Life of this trial
- Registered 1 month before it started.
- Ran for about 1 year 9 months before it stopped.
- 7 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Ahmad Tarhini
- Sponsor type
- University, hospital or other
- Conditions
- Small Cell Lung Cancer
- Interventions
- LBH589 and carboplatin with etoposide
- Participants
- 7
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.